K2X Technology & Life Science, Inc.
KBPH
OTC PK
| 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | 12/31/2020 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -500.00 | 0.00 |
| Total Revenue | -- | -- | -- | -500.00 | 0.00 |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -500.00 | 0.00 |
| SG&A Expenses | 98.20K | 107.20K | 167.00K | -- | 91.70K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 273.50K | 245.50K | 219.80K | 179.50K | 241.00K |
| Total Operating Expenses | 371.70K | 352.70K | 386.80K | 179.50K | 332.70K |
| Operating Income | -371.70K | -352.70K | -386.80K | -180.00K | -332.70K |
| Income Before Tax | 320.20K | 996.10K | -333.80K | 151.80K | -4.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 320.20K | 996.10K | -333.80K | 151.80K | -4.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 320.20K | 996.10K | -333.80K | 151.80K | -4.00K |
| EBIT | -371.70K | -352.70K | -386.80K | -180.00K | -332.70K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.01 | 0.08 | -0.03 | 0.02 | 0.00 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| EPS Diluted | 0.01 | 0.04 | -0.03 | 0.00 | 0.00 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.02 | 0.00 | -0.01 |
| Average Basic Shares Outstanding | 13.29M | 13.27M | 13.27M | 7.02M | 8.53M |
| Average Diluted Shares Outstanding | 23.52M | 27.34M | 13.27M | 35.96M | 19.27M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
